TRIB
Trinity Biotech
TRIB
TRIB
48 hedge funds and large institutions have $76M invested in Trinity Biotech in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
44% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 16
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
48
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.33M | |
| 2 | +$1.57M | |
| 3 | +$614K | |
| 4 |
SM
Senvest Management
New York
|
+$569K |
| 5 |
State Street
Boston,
Massachusetts
|
+$537K |
Top Sellers
| 1 | -$1.29M | |
| 2 | -$872K | |
| 3 | -$688K | |
| 4 |
D.E. Shaw & Co
New York
|
-$609K |
| 5 |
LAM
Lapides Asset Management
Greenwich,
Connecticut
|
-$593K |